CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	9 Months Ended
	Sep. 30, 2013	Sep. 30, 2012
Cash flows from operating activities:
Net income	$ 242,129	$ 190,561
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation	61,545	59,509
Amortization	34,700	37,289
Amortization of deferred financing costs	3,842	5,749
Deferred income taxes	(32,096)	(2,702)
Share based compensation expense	18,027	17,248
Restructuring and other costs - non-cash	843	14,207
Stock option income tax benefit	(2,262)	(11,201)
Equity in earnings from unconsolidated affiliates	(320)	5,448
Other non-cash expense	3,422	(8,354)
Changes in operating assets and liabilities, net of acquisitions:
Accounts and notes receivable-trade, net	(65,455)	(41,943)
Inventories, net	(45,284)	(54,329)
Prepaid expenses and other current assets	26,137	(23,798)
Other noncurrent assets, net	992	(2,743)
Accounts payable	(25,099)	(11,557)
Accrued liabilities	706	9,488
Income taxes payable	29,544	17,802
Other noncurrent liabilities	6,895	1,391
Net cash provided by operating activities	258,266	202,065
Cash flows from investing activities:
Capital expenditures	(73,500)	(64,859)
Cash paid for acquisitions of businesses, net of cash acquired	(3,939)	0
Proceeds from Hedge, Investing Activities	9,172	0
Payments on settlement of net investment hedges	(95,667)	(14,221)
Expenditures for identifiable intangible assets	(1,049)	(196)
Purchase of Company-owned life insurance policies	0	(1,577)
Proceeds from sale of property, plant and equipment, net	3,092	553
Net cash used in investing activities	(161,891)	(80,300)
Cash flows from financing activities:
Net change in short-term borrowings	8,789	(115,468)
Cash paid for treasury stock	(72,381)	(38,839)
Cash dividends paid	(25,895)	(23,561)
Cash paid for contingent consideration on prior acquisitions	0	(2,519)
Cash paid for acquisition of noncontrolling interests of consolidated subsidiaries	(8,960)	0
Proceeds from long-term borrowings	174,628	0
Repayments on long-term borrowings	(251,335)	0
Proceeds from exercise of stock options	48,350	24,830
Excess tax benefits from share based compensation	2,262	11,201
Interest Received on derivatives with an other than insignificant financing element	21	0
Payments for Hedge, Financing Activities	129	1,229
Net cash used in financing activities	(124,650)	(145,585)
Effect of exchange rate changes on cash and cash equivalents	(1,199)	2,767
Net (decrease) increase in cash and cash equivalents	(29,474)	(21,053)
Cash and cash equivalents at beginning of period	80,132	77,128
Cash and cash equivalents at end of period	$ 50,658	$ 56,075